The Fear Avoidance Scale of the Sickler

Grace Ababio*; Ivy Ekem; William Bill Chaplin; Isaac Quaye

**Grace Ababio*, Ivy Ekem, William Bill Chaplin and Isaac Quaye**

Volume5-Issue10
Dates: Received: 2024-09-27 | Accepted: 2024-10-16 | Published: 2024-10-17
Pages: 1313-1320

Abstract

Background: Fear, one of the psychosocial parameters, has received much attention lately. Based on previous work done elsewhere in other disease states, we sought to investigate the fear – avoidance model, biofeedback and family intervention in sickle cell patients.

Method: Out of the 852 interested participants (622 men and 230 women) that started the study, only 323 subjects fully completed the study. Two hundred and forty – two (242) subjects were diagnosed with Sickle Cell disease while 81 were not. Subjects were recruited consecutively at the outpatient unit after ethical approval and informed consent. Questionnaires were administered to subjects. One aspect of which contained the fear avoidance model of pain also called the Tampa Scale of Kinesiophobia (TSK) was assessed in the subjects. New discoveries for adaptation during the rainy season were also noted as a form of biofeedback and family intervention.

Results: Coefficient Alpha for the 8 items TSK scale was 0.88 and unidimensional. TSK scores between SCD males with painful episodes was statistically significant. Even though HbSS individuals scored relatively higher on the TSK scale, painful episodes were statistically not significant between groups, perhaps, due to the biofeedback and family intervention strategy.

Conclusion: In sickle cell anemia, musculoskeletal pain was more persistent than in HbSC disease and the biofeedback intervention was highly needful in such circumstance.

FullText HTML FullText PDF DOI: 10.37871/jbres2019

Certificate of Publication

Copyright

How to cite this article

Ababio G, Ekem I, Chaplin WB, Quaye I. The Fear Avoidance Scale of the Sickler. J Biomed Res Environ Sci. 2024 Oct 17; 5(10): 1313-1320. doi: 10.37871/jbres2019, Article ID: JBRES2019, Available at: https://www.jelsciences.com/articles/ jbres2019.pdf

Subject area(s)

Hematology

Psychiatry

References

Rachman S. Health anxiety disorders: a cognitive construal. Behav Res Ther. 2012 Aug;50(7-8):502-12. doi: 10.1016/j.brat.2012.05.001. Epub 2012 May 10. PMID: 22659160.
Lang PJ. Presidential address, 1978. A bio-informational theory of emotional imagery. Psychophysiology. 1979 Nov;16(6):495-512. doi: 10.1111/j.1469-8986.1979.tb01511.x. PMID: 515293.
Rachman S, Hodgson R. I. Synchrony and desynchrony in fear and avoidance. Behav Res Ther. 1974 Nov;12(4):311-8. doi: 10.1016/0005-7967(74)90005-9. PMID: 4155621.
Ababio G, Boateng LA, Asare EV, Reeks R, Dongdem A. Sickle cell disease pain and zinc, any link? a case-control study among patients with sickle cell disease in korle-Bu. Valley International Journal Digital Library. 2024;1:1119-29. doi: 10.18535/ijsrm/v12i08.mp01.
Ababio GK. Emerging trends in sickle cell disease and Crispr/Caspases. In: Current practices in sickle cell disease. IntechOpen; 2024. doi: 10.5772/intechopen.1004305.
Boateng LA, Asare EV, Reeks R, Ababio G. Investigating the relationship between possible assessment tools (visual analogue scale, Tampa Scale of Kinesiophobia and Brief pain inventory) that could be used for SCD pain. Valley International Journal Digital Library. 2024;1:1130-7. doi: 10.18535/ijsrm/v12i08.mp02.
Asmundson GJ, Norton PJ, Vlaeyen JW. Fear-avoidance models of chronic pain: An overview. Understanding and treating fear of pain. 2004 Jul 29:3-24. doi: 10.1093/oso/9780198525141.003.0001.
Vlaeyen JWS, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain. 2000 Apr;85(3):317-332. doi: 10.1016/S0304-3959(99)00242-0. PMID: 10781906..
Crombez G, Vlaeyen JW, Heuts PH, Lysens R. Pain-related fear is more disabling than pain itself: evidence on the role of pain-related fear in chronic back pain disability. Pain. 1999 Mar;80(1-2):329-39. doi: 10.1016/s0304-3959(98)00229-2. PMID: 10204746.
Powars DR, Chan L, Schroeder WA. Beta S-gene-cluster haplotypes in sickle cell anemia: clinical implications. Am J Pediatr Hematol Oncol. 1990 Fall;12(3):367-74. doi: 10.1097/00043426-199023000-00022. PMID: 1700639.
Francis RB Jr, Johnson CS. Vascular occlusion in sickle cell disease: current concepts and unanswered questions. Blood. 1991 Apr 1;77(7):1405-14. PMID: 2009364.
Creary M, Williamson D, Kulkarni R. Sickle cell disease: current activities, public health implications, and future directions. J Womens Health (Larchmt). 2007 Jun;16(5):575-82. doi: 10.1089/jwh.2007.CDC4. PMID: 17627395.
Williams I, Earles AN, Pack B. Psychological considerations in sickle cell disease. Nursing Clinics of North America. 1983;1;18(1):215-29. doi: 10.1016/S0029-6465(22)01726-1.
Ballas SK. More definitions in sickle cell disease: steady state v base line data. Am J Hematol. 2012 Mar;87(3):338. doi: 10.1002/ajh.22259. Epub 2011 Dec 21. PMID: 22190068.
Hudes K. The Tampa Scale of Kinesiophobia and neck pain, disability and range of motion: a narrative review of the literature. J Can Chiropr Assoc. 2011 Sep;55(3):222-32. PMID: 21886284; PMCID: PMC3154068.
Damsgård E, Fors T, Anke A, Røe C. The Tampa Scale of Kinesiophobia: A Rasch analysis of its properties in subjects with low back and more widespread pain. J Rehabil Med. 2007 Nov;39(9):672-8. doi: 10.2340/16501977-0125. PMID: 17999003.
Garra G, Singer AJ, Taira BR, Chohan J, Cardoz H, Chisena E, Thode HC Jr. Validation of the Wong-Baker FACES Pain Rating Scale in pediatric emergency department patients. Acad Emerg Med. 2010 Jan;17(1):50-4. doi: 10.1111/j.1553-2712.2009.00620.x. Epub 2009 Dec 9. PMID: 20003121.
Vowles KE, McCracken LM, McLeod C, Eccleston C. The Chronic Pain Acceptance Questionnaire: confirmatory factor analysis and identification of patient subgroups. Pain. 2008 Nov 30;140(2):284-291. doi: 10.1016/j.pain.2008.08.012. Epub 2008 Sep 27. PMID: 18824301.
Vowles KE, McCracken LM. Acceptance and values-based action in chronic pain: a study of treatment effectiveness and process. J Consult Clin Psychol. 2008 Jun;76(3):397-407. doi: 10.1037/0022-006X.76.3.397. PMID: 18540733.
Vowles KE, McCracken LM, Eccleston C. Patient functioning and catastrophizing in chronic pain: the mediating effects of acceptance. Health Psychol. 2008 Mar;27(2S):S136-43. doi: 10.1037/0278-6133.27.2(Suppl.).S136. PMID: 18377155..
Burwinkle T, Robinson JP, Turk DC. Fear of movement: factor structure of the tampa scale of kinesiophobia in patients with fibromyalgia syndrome. J Pain. 2005 Jun;6(6):384-91. doi: 10.1016/j.jpain.2005.01.355. PMID: 15943960.
Cozzi L, Tryon WW, Sedlacek K. The effectiveness of biofeedback-assisted relaxation in modifying sickle cell crises. Biofeedback Self Regul. 1987 Mar;12(1):51-61. doi: 10.1007/BF01000078. PMID: 3663738.
Gil KM, Abrams MR, Phillips G, Keefe FJ. Sickle cell disease pain: relation of coping strategies to adjustment. J Consult Clin Psychol. 1989 Dec;57(6):725-31. doi: 10.1037//0022-006x.57.6.725. PMID: 2600243.
Ashcroft MT, Serjeant GR, Desai P. Heights, weights, and skeletal age of Jamaican adolescents with sickle cell anaemia. Arch Dis Child. 1972 Aug;47(254):519-24. doi: 10.1136/adc.47.254.519. PMID: 4340016; PMCID: PMC1648274.